Risk for GATT failure leads November glaucoma coverage
Risk factors for GATT failure topped November glaucoma coverage on Healio/OSN. Read below for other popular glaucoma articles.
Younger children, those who do not receive anti-inflammatories at risk for GATT failure
Younger patients, patients who do not receive anti-inflammatory medications postoperatively and those who undergo non-circumferential angle surgery are at a higher risk for failure after gonioscopy-assisted transluminal trabeculotomy. Read more.
Late-stage neovascular glaucoma typically requires surgery, individualized management
Late-stage neovascular glaucoma can require surgical management, typically with a glaucoma drainage implant, but treatment should be individualized depending on patient factors. Read more.
Balance needed between glaucoma treatment, management of ocular surface disease
Glaucoma-related ocular surface disease is a significant and often underdiagnosed ocular comorbidity that can significantly affect quality of life. Read more.
VIDEO: Certain baseline characteristics predictive of Durysta duration of action
In this Healio Video Perspective from the virtual AAO annual meeting, Michael R. Robinson, MD, discusses patient characteristics affecting long-term IOP-lowering effects after implantation of Durysta (bimatoprost intracameral implant, AbbVie). Watch more.
VIDEO: Six-year results of iStent implantation
In this Healio Video Perspective from the virtual AAO annual meeting, Tanner Ferguson, MD, shares results from a study investigating 6-year outcomes of the iStent (Glaukos) with phacoemulsification. Watch more.